|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,299.00 INR | +2.27% |
|
+1.64% | +12.92% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.57% | -1.95% | +2.43% | +7.15% | +13.45% | +19.54% | +71.30% | +148.17% | +131.74% | 48.95B | |
| +3.09% | +5.78% | +7.70% | +8.47% | +37.16% | +64.08% | +134.31% | +180.22% | +164.74% | 39.36B | |
| +1.25% | +0.18% | +1.29% | +10.74% | -2.27% | -1.52% | +22.09% | +56.23% | +176.98% | 12.39B | |
| -1.17% | -1.31% | -2.86% | +21.46% | +21.18% | +15.39% | +70.53% | +89.53% | +194.21% | 11.76B | |
| +1.53% | -0.38% | +0.58% | +7.17% | +28.82% | +30.75% | +134.53% | +138.81% | +347.01% | 9.14B | |
| -0.25% | +2.90% | -1.79% | -7.01% | +22.45% | +18.08% | +33.63% | +38.45% | +111.00% | 7.05B | |
| +1.61% | -6.16% | -3.35% | +0.97% | +7.62% | +38.63% | -12.74% | -5.78% | -34.71% | 6.86B | |
| +0.49% | +0.37% | +2.67% | -6.12% | +11.54% | +10.59% | +182.50% | +278.96% | +169.28% | 6.7B | |
| -1.46% | +2.33% | -15.54% | -34.00% | -31.69% | -30.59% | +14.13% | +23.00% | +19.91% | 5.67B | |
| +0.96% | +2.18% | +4.33% | +19.77% | +25.33% | +31.66% | +98.65% | +129.40% | +184.82% | 4.51B | |
| -0.09% | -0.15% | -6.31% | -0.18% | +26.53% | +28.48% | -23.41% | -16.42% | -60.78% | 4.02B | |
| +1.24% | -4.67% | +6.89% | +4.61% | +2.42% | -3.84% | +71.23% | +36.37% | - | 3.97B | |
| -1.55% | +3.05% | +1.88% | +28.50% | +36.56% | +27.78% | +681.56% | +284.47% | +94.55% | 3.43B | |
| +0.07% | +12.24% | +4.80% | +3.54% | -2.96% | -3.71% | +55.02% | +196.98% | +738.41% | 2.93B | |
| +0.44% | -1.29% | +1.13% | -6.01% | +2.74% | +13.53% | +68.51% | +18.89% | +79.60% | 2.77B | |
| -0.90% | +30.51% | -22.85% | -59.68% | -28.99% | -14.32% | +146.42% | +192.73% | +1,582.98% | 2.74B | |
| -2.78% | -7.95% | -6.21% | -21.88% | -21.84% | -40.84% | +29.95% | +56.59% | +9.25% | 2.69B | |
| -1.34% | +1.60% | -5.66% | -9.03% | -1.55% | -14.57% | +18.33% | - | - | 2.65B | |
| +0.66% | +4.20% | -11.70% | -12.04% | +8.67% | -49.14% | +48.88% | +54.40% | - | 2.41B | |
| Average | +0.12% | +0.90% | -2.24% | -2.29% | +8.17% | +7.37% | +97.13% | +105.61% | +244.31% | 9.47B | |
| Weighted average by Cap. | +0.90% | -0.01% | +1.26% | +4.34% | +16.37% | +23.72% | +91.84% | +127.85% | +175.64% |
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
